Maxima Pharmaceuticals

What Maxima Pharmaceuticals does

Maxima Pharmaceuticals Inc. is a privately held Canadian pharmaceutical company founded in 1997 and headquartered in Edmonton, Alberta, that researches, manufactures, and distributes topical compounding bases used by licensed pharmacists to prepare customized medications. The company's core technology is a liposomal base — Pluronic Lecithin Organogel (PLO Gel) — sold under two registered product lines: Diffusimax, a versatile vehicle compatible with a wide range of active pharmaceutical ingredients, and Diffusimax10, an enhanced formulation designed for compounding higher drug doses and concentration combinations. Both product lines are offered in two formats, Pre-Mixed Cream (100 g and 500 g) and Compounding Kit (100 mL, 500 mL, and 1000 mL), and are listed with dedicated SKUs across every major Canadian pharmaceutical wholesaler.

The company operates a pure distribution-channel go-to-market model with no direct-to-pharmacist sales force and no digital ordering platform beyond a static product page. All purchases flow through five established Canadian distributors — McKesson Canada, Matrix Distribution Center (Shoppers Drug Mart), Lawtons Drug Store, Kohl & Frisch, and Imperial Distributors Canada — with end customers being the compounding pharmacists who buy the base vehicles on an as-needed basis. Pricing is not publicly disclosed and is set at the distributor level rather than by Maxima, with revenue realized on a one-time transactional basis rather than through subscriptions or long-term contracts.

Maxima employs 1–10 people and is the manufacturer of record but not the legal distributor. The business is founder-owned with no disclosed institutional investors, parent company, or subsidiaries, and shows no evidence of recent capital raises, acquisitions, leadership changes, or international expansion. Its value proposition is narrowly defined: supplying compounding pharmacists with a reliable, specialty PLO Gel base in two dose-handling variants and two convenience formats, leveraging 27 years of category presence rather than technology differentiation, digital capabilities, or proprietary data assets.

Name

Maxima Pharmaceuticals

Legal name

Maxima Pharmaceuticals Inc.

Website

https://maximapharmaceuticals.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1–10 employees

Short description

Maxima Pharmaceuticals is a privately held Edmonton-based manufacturer that researches and distributes Pluronic Lecithin Organogel (PLO Gel) topical compounding bases — Diffusimax and Diffusimax10 — exclusively through major Canadian pharmaceutical wholesalers to licensed compounding pharmacists.

Ownership category

akta.pro rank

Product category

Topical Compounding Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Compounding & Customized Medication Management Support (HSABALAL)

Keywords

• Topical compounding pharmaceuticals
• PLO gel formulations
• Liposomal base vehicles
• Pharmaceutical compounding bases
• Compounding pharmacy supplies

Headquarters

HQ city

Edmonton

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D

Revenue model

1. Pharmaceutical Compounding Products Sales: Maxima Pharmaceuticals generates revenue through the sale of its Diffusimax and Diffusimax10 products (both Pre-Mixed Cream and Compounding Kit formats) exclusively through pharmaceutical distributors in Canada. The revenue model is based on one-time product transactions rather than recurring subscriptions, as pharmacists purchase compounding vehicles on an as-needed basis.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Core offering

Maxima Pharmaceuticals manufactures and sells liposomal Pluronic Lecithin Organogel (PLO Gel) base vehicles under the Diffusimax and Diffusimax10 brands, used by licensed compounding pharmacists to prepare topical pharmaceutical formulations. Products are offered in two formats — Pre-Mixed Cream and Compounding Kit — and are sold exclusively through major Canadian pharmaceutical distributors.

Product overview

Maxima Pharmaceuticals provides pharmacists with high quality topical compounding solutions since 1997. The product portfolio consists of Diffusimax and Diffusimax10 (PLO Gel formulations) — liposomal base vehicles for topical compounding. Diffusimax is a versatile formulation compatible with a wide range of active pharmaceutical ingredients, while Diffusimax10 is an enhanced formulation designed for higher drug doses and concentrations. Both products are available in two formats: Pre-Mixed Cream (100g and 500g) and Compounding Kit (100ml, 500ml, and 1000ml).

Differentiator

Problem solved

Functional benefit

Brands

• Diffusimax: A liposomal base (pluronic lecithin organogel or PLO gel) used for preparing a wide range of topical formulations. Compatible with a wide range of active pharmaceutical ingredients. Available in Pre-Mixed Cream (100g, 500g) and Compounding Kit (100mL, 500mL, 1000mL) formats.
• Diffusimax10

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• McKesson CanadacoreChannel Partner/ Reseller/ DistributorMcKesson Canada is a major pharmaceutical distributor serving as Maxima Pharmaceuticals' primary distribution channel. McKesson offers the full range of Diffusimax and Diffusimax10 products in both Pre-Mixed Cream and Compounding Kit formats, making these topical compounding solutions available to pharmacists across Canada through McKesson's extensive distribution network.
• Matrix Distribution Center (Shoppers Drug Mart)coreChannel Partner/ Reseller/ DistributorMatrix Distribution Center serves as the distribution hub for Shoppers Drug Mart, one of Canada's largest pharmacy chains. Located in Calgary, AB, this partnership enables Maxima Pharmaceuticals to reach a broad network of retail and compounding pharmacies through Shoppers Drug Mart's extensive Canadian presence.
• Lawtons Drug StoreminorChannel Partner/ Reseller/ DistributorLawtons Drug Store operates as a regional pharmacy chain distributor in Atlantic Canada, based in Dartmouth, NS. The partnership provides Maxima with distribution coverage in the Nova Scotia market and broader Atlantic region.
• Kohl & FrischminorChannel Partner/ Reseller/ DistributorKohl & Frisch is a Canadian pharmaceutical wholesale distributor. The partnership enables Maxima Pharmaceuticals to distribute Diffusimax products through this wholesale channel to pharmacies across Canada.
• Imperial Distributors CanadaminorChannel Partner/ Reseller/ DistributorImperial Distributors Canada (IDCI) is a Canadian pharmaceutical distribution company. The partnership provides Maxima Pharmaceuticals with an additional distribution channel to reach compounding pharmacists across Canada.

Scale indicators1 record

Recent moves5 records

Expansion highlights2 records

Direct peers

• Fagron: Global leader in pharmaceutical compounding, supplying APIs, bases, and vehicles to compounding pharmacies worldwide including Canada (formerly Gallipot). Directly comparable as a specialty supplier of compounding ingredients and vehicles.
• PCCA (Professional Compounding Centers of America): US-based compounding pharmacy supplier offering bases, chemicals, equipment and training to compounding pharmacists. Comparable to Maxima as a specialty provider of topical and other compounding vehicles to independent compounders.
• Spectrum Pharmacy Products: Supplies compounding vehicles, chemicals, and equipment to compounding pharmacies in North America. Closely comparable to Maxima in the niche of specialty bases and excipients for compounders.
• Gallipot (Fagron Canada): Canadian subsidiary of Fagron and direct in-market competitor supplying compounding vehicles and APIs to Canadian compounding pharmacies. The closest geographic and product peer to Maxima within Canada.
• Medisca: Global supplier of pharmaceutical compounding ingredients, vehicles, and bases to compounding pharmacies, with Canadian operations. Directly comparable as a specialty compounding base and excipient supplier.
• Humco: Manufacturer and supplier of pharmaceutical compounding ingredients, vehicles, and OTC products used by pharmacists. Comparable as a specialty base/vehicle supplier to compounding pharmacies.
• Letco Medical (Leto): US pharmaceutical compounding supplier offering chemicals, APIs, bases, and supplies to compounding pharmacists. Comparable to Maxima as a specialty compounding vehicle and ingredient provider.

Broad incumbents

• McKesson Canada: One of Maxima's primary distribution partners and the dominant Canadian pharmaceutical wholesaler. Relevant as a channel partner and as a broad incumbent that could substitute or compete with Maxima's offerings through private label.

Emerging players

• Compounding Pharmacy of America: US-based specialty compounding pharmacy that also supplies bases and ingredients to other compounders. Comparable thematically to Maxima as a topical compounding specialist, though operating more as a compounder than a base manufacturer.
• ApothéCure (AnazaoHealth): Specialty compounding pharmacy and supplier of compounded preparations including topical formulations. Comparable as a niche participant in topical compounding, though more focused on finished preparations than bases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maxima Pharmaceuticals